The art of innovation: clinical development of trastuzumab deruxtecan and redefining how antibody-drug conjugates target HER2-positive cancers
Antoine Yver, Toshinori Agatsuma, Jean‐Charles Soria
Topics & Concepts
MedicineTrastuzumabAntibody-drug conjugateDrugDrug developmentOncologyPayload (computing)Internal medicineAntibodyChemotherapyPharmacologyCancerImmunologyMonoclonal antibodyBreast cancerNetwork packetComputer networkComputer scienceHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchLung Cancer Treatments and Mutations